Healio

FDA allows Aerie to change primary endpoint range for Rocket 2 trial of Rhopressa

Please provide your email address to receive an email when new articles are posted on . The FDA has allowed Aerie Pharmaceuticals to change the primary endpoint range of Rocket 2, a second phase 3 ...
BBC

How Endpoint claimed the Elite Series Rocket League crown

Endpoint beat Epsilon 4-2 in the final of the Gfinity Elite Series Rocket League competition to secure the inaugural title and a £20,000 cash prize. © 2024 BBC. The ...
Business Wire

Aerie Pharmaceuticals Initiates Fourth Phase 3 Clinical Trial of Rhopressa TM

The Rocket 4 clinical trial design includes the same clinical endpoint ranges used for our successful Rocket 2 clinical trial, from above 20 mmHg to below 25 mmHg, and is designed to provide ...
The Financial

Phase III J-ROCKET AF Study of Bayer’s Xarelto® (rivaroxaban) Meets Primary Endpoint

The FINANCIAL — Berlin, Germany, July 25, 2011 – Conducted in Japan, the Phase III J-ROCKET AF study of Bayer’s once-daily Xarelto® (rivaroxaban) in Japanese patients with non-valvular atrial ...
BBC

Endpoint score with incredible assist to make Rocket League final

Endpoint's Tinny and Shakahron combine brilliantly to score as they stunned favourites Infused 4-1 in the semi-finals of the Elite Series Rocket League competition. They'll face Epsilon in Friday's ...